Advertisement
U.S. markets open in 8 minutes

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD
131.75+6.23 (+4.96%)
At close: 04:00PM EDT
132.39 +0.64 (+0.49%)
Pre-Market: 09:21AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close125.52
Open132.87
Bid132.47 x 1200
Ask132.51 x 1000
Day's Range130.11 - 133.10
52 Week Range99.14 - 133.10
Volume15,841,389
Avg. Volume8,735,054
Market Cap333.675B
Beta (5Y Monthly)0.38
PE Ratio (TTM)941.07
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield3.08 (2.34%)
Ex-Dividend DateMar 14, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Merck & Company, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    14 hours agoMorningstar
View more